Intuitive Surgical (NASDAQ:ISRG) Given a $633.00 Price Target at Piper Jaffray Companies
Intuitive Surgical (NASDAQ:ISRG) has been given a $633.00 price target by investment analysts at Piper Jaffray Companies in a research note issued on Friday, TipRanks reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Piper Jaffray Companies’ target price points to a potential upside of 11.79% from the stock’s current price.
Several other equities analysts also recently issued reports on the stock. Wells Fargo & Co set a $620.00 price objective on shares of Intuitive Surgical and gave the company a “buy” rating in a research note on Friday. Canaccord Genuity reiterated a “buy” rating and set a $610.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research note on Friday, July 19th. UBS Group increased their target price on shares of Intuitive Surgical from $560.00 to $590.00 and gave the stock a “neutral” rating in a research note on Friday. Royal Bank of Canada set a $570.00 target price on shares of Intuitive Surgical and gave the stock a “hold” rating in a research note on Friday. Finally, Northland Securities set a $375.00 target price on shares of Intuitive Surgical and gave the stock a “sell” rating in a research note on Friday, July 19th. Three research analysts have rated the stock with a sell rating, four have assigned a hold rating and ten have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $583.00.
NASDAQ ISRG traded up $36.85 during trading hours on Friday, hitting $566.25. The company had a trading volume of 2,302,938 shares, compared to its average volume of 574,302. Intuitive Surgical has a 1-year low of $430.24 and a 1-year high of $589.32. The company has a market cap of $61.02 billion, a PE ratio of 59.67, a price-to-earnings-growth ratio of 3.89 and a beta of 1.13. The business has a 50 day moving average of $521.84 and a 200-day moving average of $517.32.
In other news, Director Lonnie M. Smith sold 215 shares of the stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $493.18, for a total transaction of $106,033.70. Following the completion of the sale, the director now owns 330,868 shares in the company, valued at $163,177,480.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Jamie Samath sold 259 shares of the stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $532.14, for a total transaction of $137,824.26. Following the transaction, the vice president now directly owns 277 shares of the company’s stock, valued at $147,402.78. The disclosure for this sale can be found here. Insiders have sold 25,869 shares of company stock valued at $13,664,252 in the last quarter. Insiders own 1.70% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Manchester Financial Inc. purchased a new position in Intuitive Surgical during the second quarter worth about $25,000. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its holdings in Intuitive Surgical by 733.3% during the second quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 75 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 66 shares in the last quarter. North Star Investment Management Corp. purchased a new position in Intuitive Surgical during the third quarter worth about $49,000. FNY Investment Advisers LLC purchased a new position in Intuitive Surgical during the second quarter worth about $47,000. Finally, Motco purchased a new position in Intuitive Surgical during the second quarter worth about $51,000. 85.90% of the stock is owned by hedge funds and other institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Read More: Short Selling Stocks and Day Traders
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.